4-formyl-9,23,35,49-tetrahydroxy-30-(hydroxymethyl)-3,6,15,18,22,29,32,41,48-nonamethyl-53,54,55,56-tetraoxo-16,42-bis({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)-12,26,38,52-tetraoxanonacyclo[48.2.1.1~10,13~.,136765-20-3 Products Supply

Name: 4-formyl-9,23,35,49-tetrahydroxy-30-(hydroxymethyl)-3,6,15,18,22,29,32,41,48-nonamethyl-53,54,55,56-tetraoxo-16,42-bis({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)-12,26,38,52-tetraoxanonacyclo[48.2.1.1~10,13~.
CAS NO.: 136765-20-3
Synonyms:
Quartromicin A2;BU-3889V A2;136765-20-3;2a,25,26,30,32a,35,36,40,44a-hexadecahydro-45,46,47,48-tetrahydroxy-34-(hydroxymethyl)-3,10a,13,19,22a,25,32a,35,41,44a-decamethyl-6,8,16,18,28,30,38,40-octaoxo-;4a,7:14a,17:26a,29:36a,39-Tetrametheno-6H,16H,28H,38H-tetrabenzo(b,j,t,b1)(1,9,19,27)tetraoxacyclohexatriacontin-12-carboxaldehyde, 2,24-bis((alpha-D-galactopyranosyloxy)methyl)-3,4,8,10a,13,14,18,22a,25,26,30,32a,35,36,40,44a-hexadecahydro-45,46,47,48-tetrahydroxy-34-(hydroxymethyl)-3,10a,13,19,22a,25,32a,35,41,44a-decamethyl-6,8,16,18,28,30,38,40-octaoxo-;4a,7:14a,17:26a,29:36a,39-Tetrametheno-6H,16H,28H,38H-tetrabenzo[b,j,t,b1][1,9,19,27]tetraoxacyclohexatriacontin-12-carboxaldehyde, 2,24-bis[(.alpha.-D-galactopyranosyloxy)methyl]-3,4,8,10a,13,14,18,2
Molecular Structure:
Molecular Formula: C₇₇H₁₀₀O₃₀

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 1/C51H74N2/c1-5-9-13-17-21-49(; 4-formyl-9,23,35,49-tetrahydro; 1/C28H41N5O15S.Na/c1-12(2)21(2; 9,23,35,49-tetrahydroxy-4,30-b; 4,30-diformyl-9,23,35,49-tetra; 1/C33H42O7/c1-19-25-17-24-18-2; 1/C27H27N3O3S/c1-30-25(20-11-1; 3-heptyl-5-hydroxyphenyl 2-hep; 1/C21H26N2O4/c1-3-14-8-9-19(25; 1/C26H18O2/c1-17-16-23-21-9-5-; (2R,3S,4R,5R)-2,3,4,5-tetrahyd; 1/C30H52/c1-10-25(6)16-12-20-3; (2R,3R,4R,5R)-2,3,5,6-tetrahyd; 1/C22H28O6/c1-23-17-11-21(27-5; (2S)-4-{[(2R,3R,4R,5S,6R)-3-(a; (1S,2R,18R,19R,22S,25R,28R,40S; (2R,3R,4S,5R,6S)-2-(hydroxymet; (1S,2R,18R,19R,22S,25R,28R,40S; 1/C18H19NO4/c1-22-15-8-11-10(7; trisodium; 4-(chlorosulfamoyl); (E)-4-((6S,8R,10S,11aS,E)-9-et; 1/C19H15ClN2O2S/c1-11-19(23)24; Dispiro[furan-2(3H),2'(13'H)-b; 1/C18H18O6/c1-22-14-8-13(20)15; (2S,3R,4S,5R,6S)-6-{[(2S,3S,4S; 1/C17H22N6/c1-2-8-19-13-11-14(; 9-[2-carboxy-4-hydroxy-10-oxo-; (11E,11’E)-(S)-3-(((2R,3R,4S,; N-[(2R,3R,4S,5R)-4-[(2S,3R,4R,; methyl (2S,3R,4S)-3-ethyl-4-((;